Mar 22 |
Relief Therapeutics grants exclusive U.S. rights to Eton Pharmaceuticals for PKU GOLIKE
|
Mar 22 |
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
|
Mar 15 |
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript
|
Mar 15 |
Q4 2023 Eton Pharmaceuticals Inc Earnings Call
|
Mar 15 |
Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript
|
Mar 14 |
Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...
|
Mar 14 |
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
|
Mar 14 |
Eton Pharmaceuticals GAAP EPS of -$0.09 misses by $0.05, revenue of $7.3M misses by $0.36M
|
Mar 14 |
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 14 |
Earnings Scheduled For March 14, 2024
|